Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Michael Pazianas"'
Autor:
Michael Pazianas
Publikováno v:
JBMR Plus, Vol 5, Iss 8, Pp n/a-n/a (2021)
Externí odkaz:
https://doaj.org/article/43c7a25bd4e1462a959e6f3e49b6aead
Publikováno v:
Therapeutics and Clinical Risk Management, Vol 2011, Iss default, Pp 131-144 (2011)
Michael Pazianas1, Cyrus Cooper1,2, Yiting Wang3, Jeff L Lange4, R Graham G Russell1,51The Botnar Research Centre, Oxford University, Oxford, UK; 2MRC Epidemiology Resource Centre, University of Southampton, Southampton, UK; 3Warner Chilcott Pharmace
Externí odkaz:
https://doaj.org/article/f21f6e551429497bb2e2f6c510647b14
Publikováno v:
Therapeutics and Clinical Risk Management, Vol 2010, Iss default, Pp 325-343 (2010)
Michael Pazianas1, Cyrus Cooper1,2, F Hal Ebetino3, R Graham G Russell1,41The Botnar Research Centre and Oxford University Institute of Musculoskeletal Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Diseases, Nuffield
Externí odkaz:
https://doaj.org/article/8992ef11918d4ac69b780bd2621ed855
Autor:
Michael Pazianas, Paul D. Miller
Publikováno v:
Journal of Nephrology.
Autor:
Michael, Pazianas
Publikováno v:
Calcified tissue international.
Autor:
Michael, Pazianas
Publikováno v:
Bone. 165:116561
Autor:
Michael Pazianas
Publikováno v:
Bone. 153
Autor:
Paul D. Miller, Michael Pazianas
Management of osteoporosis in patients with chronic kidney disease (CKD) is often very challenging and it should consider the pathophysiology of both disorders. Patients with stage 4–5 CKD are especially at very high risk for fragility fractures an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d82784c285628265fd8dcee2960c5500
https://doi.org/10.1093/med/9780198870197.003.0086
https://doi.org/10.1093/med/9780198870197.003.0086
Autor:
Michael Pazianas
Publikováno v:
JBMR Plus
JBMR Plus, Vol 5, Iss 8, Pp n/a-n/a (2021)
JBMR Plus, Vol 5, Iss 8, Pp n/a-n/a (2021)
Autor:
Stylianos Panagoutsos, Ploumis Pasadakis, Thomas L. Nickolas, Vassilis Vargemezis, William D. Fraser, Fiona E. McCann, Michael Pazianas, Pascale Khairallah
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims End stage kidney disease (ESKD) is associated with a malnutrition-inflammation complex that results in several endocrine, musculoskeletal, and metabolic abnormalities. Despite the known resultant derangements from this process, fe